merkel cell carcinoma Archives - BiomolBiomed Viewpoints

October 12, 2024

Latest posts

[ October 4, 2024 ] The Reviewer of the Month for October 2024: Roozbeh Heidarzadehpilehrood, MSc, PhD Reviewer of the Month
[ October 1, 2024 ] Streptococcus anginosus: A New Pathogen in Gastritis and Gastric Cancer Author Summary
[ September 3, 2024 ] The Reviewer of the Month for September 2024: Malik Galijasevic, MD, PhD Reviewer of the Month
[ August 29, 2024 ] Neuromodulation guide for the non-neuromodulator clinician: What it is and how it can benefit patients? Author Summary
[ August 15, 2024 ] Pathology and Beyond: The Multifaceted Career of Dr. Ivan Damjanov Interview

Recent advances in cancer immunotherapy based in immune checkpoint inhibitors

June 9, 2017 0

Targeted therapy based on the immune checkpoint inhibitors (Anti-PD1/PD-L1) has revolutionized cancer treatment and outcome of several solid and hematologic malignancies, including non-small cell lung carcinoma (NSCLC), metastatic renal cell carcinoma, metastatic malignant melanoma, advanced/metastatic […]